PMCB PharmaCyte Biotech, Inc.
Healthcare$0.79-3.01%ClosedMarket Cap: $5.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.19
P/S
0.00
EV/EBITDA
1.14
DCF Value
$2.49
FCF Yield
-87.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-7.7%
ROA
-5.9%
ROIC
-9.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | NaN% | $-2.1M | $746.9K | $— | — |
| Q2 null | $0.00 | NaN% | $-1.4M | $-7.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-848.3K | $-8.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.0M | $11.7M | $— | — |
| FY null | $0.00 | NaN% | $-4.4M | $30.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-960.0K | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.1M | $-1.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.3M | $23.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.2M | $1.3M | $— | — |
| FY null | $0.00 | NaN% | $-6.5M | $333.8K | $— | — |
| Q3 2024 | $0.00 | NaN% | $-1.9M | $-620.0K | $-0.65 | — |
| Q2 2024 | $0.00 | NaN% | $-1.4M | $2.8M | $-0.26 | — |